tirzepatide gut health Tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), positively impacts the altered microbiota of obese, diabetic, ovariectomized mice GLP-1 & Gut - How
Description
Common side effects include nausea, constipation, or mild gastrointestinal discomfort as the body adjusts to the medication
Semaglutide is not recommended if you do not have diabetes
Week 3-4: first results Here's where it gets interesting
Pain may radiate to flank or groin can mimic renal colic
People in the study said they took their medication as prescribed 95% of the time after three months and 89% of the time after six months
